Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$305,558,778
-$161,222,367 QoQ
Shares Held
4,252,140
+7.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $463,988,771 across 11 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (65.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
4,252,140 | $305,558,778 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,356,009 | $45,941,583 | |
| 3 | HLN |
Haleon plc
|
3,095,451 | $28,880,557 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,674,005 | $26,834,300 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
707,194 | $17,404,044 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
29,023 | $15,725,531 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
69,482 | $11,710,496 | |
| 8 | VTRS |
Viatris Inc
|
644,514 | $10,234,881 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,558,778 | 4,252,140 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $466,781,145 | 3,948,745 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $300,339,762 | 2,387,059 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $94,661,138 | 646,946 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,443,904 | 631,253 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $102,137,004 | 620,328 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $94,124,660 | 577,700 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $110,433,074 | 565,222 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $105,970,460 | 611,274 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $99,746,079 | 589,481 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $113,708,408 | 576,118 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $113,537,259 | 652,588 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $124,888,413 | 725,210 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $132,674,317 | 797,130 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $144,595,902 | 986,666 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $142,330,076 | 959,809 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $186,617,534 | 1,085,680 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $155,507,164 | 824,578 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $132,264,015 | 541,999 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $111,579,634 | 574,738 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $125,256,096 | 672,119 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $112,278,987 | 712,973 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $83,124,526 | 502,263 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $68,829,308 | 416,214 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $61,479,569 | 448,625 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $49,535,249 | 420,896 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||